Metformin Hydrochloride Tablet
Product Images NDC 68645-582

9 FDA label images from Legacy Pharmaceutical Packaging, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 68645-582). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Legacy Pharmaceutical Packaging, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Table 1 (Metformin Granules 1)

Table 1 (Metformin   Granules 1)
A data table comparing the incidence of various side effects between Metformin Hydrochloride Tablets (n=141) and Placebo (n=145). Side effects listed include diarrhea, nausea/vomiting, flatulence, asthenia, indigestion, abdominal discomfort, and headache, with percentage values for each group.*
FDA Label Image

Table 3 (Metformin Granules 2)

Table 3 (Metformin   Granules 2)
A text panel listing clinical impacts, interventions, and examples related to interactions with metformin hydrochloride tablets. It covers carbonic anhydrase inhibitors, drugs reducing metformin clearance, alcohol, insulin secretagogues or insulin, and drugs affecting glycemic control, highlighting effects on serum bicarbonate, renal elimination, lactic acidosis risk, hypoglycemia, and glycemic control.*
FDA Label Image

Formula (Metformin Granules 3)

Formula (Metformin   Granules 3)
Chemical structure of Metformin hydrochloride showing its molecular formula with nitrogen, carbon, hydrogen, and chlorine atoms arranged to depict the biguanide chemical configuration typical for this active ingredient.*
FDA Label Image

Table 4 (Metformin Granules 4)

Table 4 (Metformin   Granules 4)
A data table presenting pharmacokinetic parameters of Metformin Hydrochloride Tablets in various subject groups. It summarizes the maximum concentration (Cmax), time to maximum concentration (Tmax), and renal clearance rates for doses of 500 mg and 850 mg in healthy adults, adults with type 2 diabetes, elderly healthy adults, and renal-impaired adults categorized by mild, moderate, and severe renal function impairment.*
FDA Label Image

Table 5 (Metformin Granules 5)

Table 5 (Metformin   Granules 5)
A data table showing drug interaction information for Metformin hydrochloride tablets. It lists coadministered drugs, their doses, doses of Metformin, and geometric mean ratios for AUC and Cmax comparing with and without the coadministered drug. Drugs with no dosing adjustments required include Glyburide, Furosemide, Nifedipine, Propranolol, and Ibuprofen. Cimetidine and Topiramate are also listed with notes on their effects on Metformin elimination and metabolic acidosis risk.*
FDA Label Image

Table 6 (Metformin Granules 6)

Table 6 (Metformin   Granules 6)
A data table comparing the dose of various coadministered drugs and 850 mg dose of metformin, showing geometric mean ratios of AUC and Cmax with and without metformin. It lists glyburide, furosemide, nifedipine, propranolol, ibuprofen, and cimetidine with respective dose details and interaction metrics indicating no dosing adjustments required.*
FDA Label Image

Package Label.principal Display Panel (Metformin HCl 500mg)

Package Label.principal Display Panel (Metformin HCl 500mg)
Label for Metformin Hydrochloride Tablets, USP 500 mg oral tablets, containing 60 tablets per package. The label includes the NDC 68645-582-59, indicates prescription use only, and shows the tablets embossed with 'G 10'. It is manufactured by Granules India Limited, Hyderabad, India, distributed by Wal-Mart, Bentonville, AR, and packaged by Legacy Pharmaceutical Packaging LLC, Earth City, MO. Storage and handling instructions are also provided.*
FDA Label Image

Package Label.principal Display Panel (Metformin HCl 850mg)

Package Label.principal Display Panel (Metformin HCl 850mg)
Metformin Hydrochloride Tablets USP 850 mg oral tablets label for a bottle of 60 tablets. The label shows the active ingredient metformin hydrochloride with strength 850 mg. It is distributed by Wal-Mart and manufactured by Granules India Limited. The packaging is by Legacy Pharmaceutical Packaging LLC in Earth City, MO. The label includes storage instructions and a barcode.*
FDA Label Image

Package Label.principal Display Panel (Metformin HCl 1000mg)

Package Label.principal Display Panel (Metformin HCl 1000mg)
Label for Metformin Hydrochloride Tablets USP 1000 mg, oral tablets packaged in a 60-count bottle. The label displays the product name and strength prominently in black and blue text, with an image of the white, oval tablet marked with 'G 12.' The labeler is Legacy Pharmaceutical Packaging LLC, Earth City, MO. The label also notes the product is manufactured by Granules India Limited and distributed by Wal-Mart.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.